Application no. and date | 09788983.6 (espacenet) (Federated) (European Patent Register), 20090722 | Patent/reg. no. and date | DK/EP 2326621, 20160608 | Publication date | 20110601 | Priority no. and date | US 135672 P, 20080723, US 209374 P, 20090306 | EP pub. no. and date |
EP 2326621 20110601 | Effective date | | Applicant/owner | Arena Pharmaceuticals, Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | P81604133DK00E | Inventor | Jones, Robert M., 10937 Corte Luz Del Sol
San Diego California 92130, US, ULLMAN, Brett, 3046 40th Street
San Diego California 92105, US, BUZARD, DAniel J., 14494 Janal Way
San Diego California 92129, US, HAN, Sangdon, 9953 Fieldthorn Street
San Diego California 92127, US, LEHMANN, Juerg, 9840 La Tortola Ct.
San Diego California 92129, US, MOODY, Jeanne V., 5264 Bloch Street
San Diego California 92122, US, ZHU, Xiuwen, 11367 Black Colt Lane
San Diego California 92130, US, STIRN, Scott, 14710 Carmel Ridge Road
San Diego California 92128, US, KIM, Sun Hee, 8936 Revelstoke Way
San Diego California 92126, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/403 (2006.01) , A61P 37/00 (2006.01) , C07D 209/70 (2006.01) , C07D 209/88 (2006.01) , C07D 401/12 (2006.01) , C07D 403/12 (2006.01) , C07D 417/12 (2006.01) | Title | Substitueret 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl-
eddikesyrederivater, der er egnede til behandling af autoimmune og inflammatoriske lidelser | Int. application no. | US2009004265 | Int. publication no. | WO2010011316 | Related patent (certificate) | CA 2024 00030 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|